CHINA RESOURCES BOYA BIO-PHARMACEUTICAL GROUP CO.,LTD

Other languages China Resources Boya Bio-pharmaceutical Group Co.,Ltd

Equities

300294

CNE100001FF1

End-of-day quote Shenzhen S.E. Other stock markets 06:00:00 2024-05-30 pm EDT			5-day change	1st Jan Change
32.92 ^CNY	+0.30%		+0.95%	-2.26%

May. 27	Morgan Stanley Starts China Resources Boya Bio-pharmaceutical Group at Equal-weight; Price Target is 37 Yuan	MT
Apr. 23	China Resources Boya Bio-pharmaceutical Group Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Other languages

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Morgan Stanley Starts China Resources Boya Bio-pharmaceutical Group at Equal-weight; Price Target is 37 Yuan	May. 27
China Resources Boya Bio-pharmaceutical Group Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024	Apr. 23
China Resources Boya Bio-Pharmaceutical Group Co.,Ltd. Approves Cash Dividend for the Year 2023	Apr. 15
China Resources Boya Bio-Pharmaceutical Group Co.,Ltd Proposes Cash Dividend	Mar. 24
CR Boya Bio-Pharmaceutical's 2023 Profit Falls on Lower Revenue	Mar. 14
China Resources Boya Bio-pharmaceutical Group Co.,Ltd Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 13
CR Boya Bio-Pharmaceutical Signs 29.5 Million Yuan Construction Contract for Blood Products Facility	Feb. 06
China Resources Double-Crane Pharmaceutical Co.,Ltd. completed the acqyusution 89.681% stake in Guizhou Tianan Pharmaceutical Company from Jiangxi Boya Pharmaceutical Investment Co., Ltd and China Resources Boya Bio-pharmaceutical Group Co.,Ltd.	Nov. 02
CR Boya Bio-Pharmaceutical's January-September Profit Increases	23-10-25
China Resources Boya Bio-pharmaceutical Group Co.,Ltd Reports Earnings Results for the Nine Months Ended September 30, 2023	23-10-25
China Resources Double-Crane Pharmaceutical Co.,Ltd. agreed to acquire an 89.681% stake in Guizhou Tianan Pharmaceutical Company from Jiangxi Boya Pharmaceutical Investment Co., Ltd and China Resources Boya Bio-pharmaceutical Group Co.,Ltd for CNY 260 million	23-09-27
China Resources Pharmaceutical Commercial Group Company Limited completed the acquisition of 75% stake in Guangdong Fuda Pharmaceutical Co., Ltd. from China Resources Boya Bio-pharmaceutical Group Co., Ltd..	23-09-24
China Resources Pharmaceutical Commercial Group Company Limited agreed to acquire 75% stake in Guangdong Fuda Pharmaceutical Co., Ltd. from China Resources Boya Bio-pharmaceutical Group Co., Ltd. for approximately CNY 360 million.	23-08-29
China Resources Pharmaceutical's Subsidiaries Log Increases in H1 Profits	23-08-25
China Resources Boya's H1 Attributable Profit Jumps 16.9%	23-08-22
China Resources Boya Bio-pharmaceutical Group Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-21
China Resources Boya Bio-pharmaceutical Group's Q1 Profit Rises	23-04-24
China Resources Boya Bio-pharmaceutical Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-04-24
China Resources Boya Bio-pharmaceutical Group Co., Ltd. Approves Cash Dividend for 2022, Payable on 28 April 2023	23-04-17
CR Boya Bio-pharmaceutical Estimates Higher Q1 Profit	23-04-11

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages China Resources Boya Bio-pharmaceutical Group Co.,Ltd

Equities

300294

CNE100001FF1

Other languages

Filters